The technology is designed to address the limitations of existing pressure sensors.
The company will use the proceeds to create the lead programme Levodopa Cyclops.
Colorectal cancer (CRC) is the third most diagnosed cancer worldwide.
The two blood-based biomarker assays, Lumipulse G ApoE4 and Lumipulse G Pan-ApoE, are intended for research use only.
Mozarc Medical is co-owned by Medtronic and DaVita, with each company having an equal equity stake.
Give your business an edge with our leading industry insights.